GoAI
Get started
Concentra Group Holdings Parent, Inc. logo

Concentra Group Holdings Parent, Inc.

CON

NYSEHealthcareMedical - Care Facilities

Open in GoAI

Previous close

$35.00

+$0.19 · +0.55%

Aug 21, 4:00 PM ET

CON company overview

Regular session · ET · Market data may be delayed.

GoAI snapshot

AI-powered factor overview

Jul 10, 2026

GoAI score

Buy

Favorable setup — positive multi-factor alignment

Valuation

95

Deep Value

Momentum

68

Gaining

Sentiment

55

Mixed

Risk resilience

80

Low Risk

Full GoAI research

Thesis, catalysts, evidence, and risk analysis.

View full GoAI research

AI-generated, informational only, and not investment advice.

Company profile

Company website

Concentra Group Holdings Parent, Inc. is a U.S.-based provider of occupational health solutions. The company delivers a comprehensive suite of occupational and consumer health services, encompassing treatment for workers' compensation injuries, urgent care, diagnostic clinical testing, preventative health measures, and employer-specific programs, along with wellness initiatives. These services are accessible through their network of occupational health centers and onsite clinics. Furthermore, Concentra offers specialized solutions like Concentra Telemed, a telemedicine platform for addressing work-related injuries and illnesses and supporting employer services; Concentra Pharmacy, providing pharmaceutical solutions; and Concentra Medical Compliance Administration, a third-party administrative service that assists employers in managing drug abuse testing programs for both regulated and non-regulated workforces. Established in 1979 and headquartered in Mechanicsburg, Pennsylvania, the company functions as a subsidiary of Select Medical Corporation.

Industry
Medical - Care Facilities
Sector
Healthcare
Headquarters
US
CEO
William Keith Newton
Listed since
Jul 25, 2024
Employees
9,983

Market position

Day range

Current $35.00

52-week range

Current $35.00

Open
$35.035
Previous close
$34.81
Volume
586.77K
0.64× average
Average volume
922.04K
Average daily volume
Market cap
4.48B USD
Beta
0.69
Market reference 1
50-day average
$31.474
+11.20% above average
200-day average
$24.4388
+43.21% above average

Financials

Financial snapshot

Latest / TTM

Valuation & yield

Enterprise value
4.52B USD
P/E (TTM)
22.58×
P/B (TTM)
9.29×
P/S (TTM)
1.96×
EV / EBITDA
11.04×
Earnings yield
6.68%
Free cash flow yield
7.91%
Dividend yield
0.71%

Profitability & efficiency

Gross margin
29.31%
Operating margin
16.39%
Net margin
8.69%
Return on equity
42.31%
Return on assets
5.48%
Return on invested capital
9.22%

Financial health

Debt / equity
4.49×
Current ratio
1.14×
Altman Z-score
2.42
Piotroski F-score
8 of 9

Financial statements

Margin trends

Profitability as a percentage of reported revenue.

Gross marginOperating marginNet margin
Gross, operating, and net margin trends30%22%14%6%Gross margin, FY2021: 24.71%Gross margin, FY2022: 23.67%Gross margin, FY2023: 27.88%Gross margin, FY2024: 27.79%Gross margin, FY2025: 28.34%Operating margin, FY2021: 15.60%Operating margin, FY2022: 14.97%Operating margin, FY2023: 15.65%Operating margin, FY2024: 16.04%Operating margin, FY2025: 15.44%Net margin, FY2021: 12.06%Net margin, FY2022: 9.67%Net margin, FY2023: 9.79%Net margin, FY2024: 8.76%Net margin, FY2025: 7.69%FY2021FY2022FY2023FY2024FY2025
Gross margin FY2021 24.71%. Gross margin FY2022 23.67%. Gross margin FY2023 27.88%. Gross margin FY2024 27.79%. Gross margin FY2025 28.34%. Operating margin FY2021 15.60%. Operating margin FY2022 14.97%. Operating margin FY2023 15.65%. Operating margin FY2024 16.04%. Operating margin FY2025 15.44%. Net margin FY2021 12.06%. Net margin FY2022 9.67%. Net margin FY2023 9.79%. Net margin FY2024 8.76%. Net margin FY2025 7.69%.

Income trends

Revenue

2.16B USD+13.85%

Operating income

333.99M USD+9.59%

Net income

166.42M USD-0.08%
Income trends across reported periods2.36B USD1.56B USD765.52M USD−33.29M USDRevenue, FY2021: 1.73B USDRevenue, FY2022: 1.72B USDRevenue, FY2023: 1.84B USDRevenue, FY2024: 1.9B USDRevenue, FY2025: 2.16B USDOperating income, FY2021: 270.27M USDOperating income, FY2022: 258.22M USDOperating income, FY2023: 287.63M USDOperating income, FY2024: 304.76M USDOperating income, FY2025: 333.99M USDNet income, FY2021: 208.88M USDNet income, FY2022: 166.73M USDNet income, FY2023: 179.95M USDNet income, FY2024: 166.54M USDNet income, FY2025: 166.42M USDFY2021FY2022FY2023FY2024FY2025
Revenue FY2021 1.73B USD. Revenue FY2022 1.72B USD. Revenue FY2023 1.84B USD. Revenue FY2024 1.9B USD. Revenue FY2025 2.16B USD. Operating income FY2021 270.27M USD. Operating income FY2022 258.22M USD. Operating income FY2023 287.63M USD. Operating income FY2024 304.76M USD. Operating income FY2025 333.99M USD. Net income FY2021 208.88M USD. Net income FY2022 166.73M USD. Net income FY2023 179.95M USD. Net income FY2024 166.54M USD. Net income FY2025 166.42M USD.
Metric (USD)FY2025FY2024FY2023FY2022FY2021
Revenue2.16B USD1.9B USD1.84B USD1.72B USD1.73B USD
Cost of goods sold1.55B USD1.37B USD1.33B USD1.32B USD1.3B USD
Gross profit613.09M USD527.98M USD512.43M USD408.19M USD427.98M USD
Selling, general, and administrative203.31M USD156.32M USD152M USD149.98M USD157.71M USD
Operating expenses279.1M USD223.21M USD224.8M USD149.98M USD157.71M USD
Interest expense109.29M USD69.69M USD114.04M USD31.64M USD31.86M USD
Depreciation and amortization75.82M USD67.18M USD73.05M USD73.67M USD82.21M USD
Operating income333.99M USD304.76M USD287.63M USD258.22M USD270.27M USD
Net income166.42M USD166.54M USD179.95M USD166.73M USD208.88M USD

Company facts updated Aug 24, 2026.

Earnings

EPS beat rate
89%
8 beats, 0 misses, 1 met estimate
Average EPS surprise
+8.98%
9 comparable reports
Latest EPS result
0.52
Estimate 0.42 · Beat by 23.34%

EPS: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly EPS actual values compared with estimates0.560.420.280.14Q1 '25BeatQ2 '25BeatQ3 '25MetQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 3, 2025: actual 0.17, estimate 0.16, surprise +6.25%, Beat. Q2 2025, reported May 7, 2025: actual 0.32, estimate 0.31, surprise +3.23%, Beat. Q3 2025, reported Aug 7, 2025: actual 0.37, estimate 0.37, surprise 0.00%, Met estimate. Q4 2025, reported Nov 6, 2025: actual 0.39, estimate 0.37, surprise +5.41%, Beat. Q1 2026, reported Jan 28, 2026: actual 0.28, estimate 0.227, surprise +23.46%, Beat. Q2 2026, reported May 7, 2026: actual 0.4, estimate 0.35, surprise +14.29%, Beat. Q3 2026, reported Aug 6, 2026: actual 0.52, estimate 0.422, surprise +23.34%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 0.43, surprise —, Comparison unavailable.

Revenue: actual versus estimate

Recent quarterly results

ActualEstimate
Quarterly Revenue actual values compared with estimates630.27M567.11M503.96M440.8MQ1 '25MissQ2 '25BeatQ3 '25BeatQ4 '25BeatQ1 '26BeatQ2 '26BeatQ3 '26BeatQ4 '26Estimate
Q1 2025, reported Mar 3, 2025: actual 465.04M USD, estimate 486.62M USD, surprise -4.43%, Miss. Q2 2025, reported May 7, 2025: actual 500.75M USD, estimate 496.06M USD, surprise +0.95%, Beat. Q3 2025, reported Aug 7, 2025: actual 550.79M USD, estimate 537.36M USD, surprise +2.50%, Beat. Q4 2025, reported Nov 6, 2025: actual 572.8M USD, estimate 532M USD, surprise +7.67%, Beat. Q1 2026, reported Jan 28, 2026: actual 539.1M USD, estimate 532.1M USD, surprise +1.32%, Beat. Q2 2026, reported May 7, 2026: actual 569.56M USD, estimate 553.53M USD, surprise +2.90%, Beat. Q3 2026, reported Aug 6, 2026: actual 606.03M USD, estimate 591.75M USD, surprise +2.41%, Beat. Q4 2026, reported Nov 5, 2026: actual —, estimate 605.14M USD, surprise —, Comparison unavailable.

Analyst ratings

Third-party consensus; not a GoAI recommendation.

Analyst price target

Average target

$38.60

10.29% upside
Past 12 months12-month forecastHigh $42.00Average $38.60Low $30.00

Rating distribution

6 ratings
Strong buy00%
Buy6100%
Hold00%
Sell00%
Strong sell00%

Recent analyst actions

6 institutions
Goldman SachsmaintainBuy
JP MorganmaintainOverweight

CON news

zacks.com

Concentra Group (CON) is a Great Momentum Stock: Should You Buy?

Does Concentra Group (CON) have what it takes to be a top stock pick for momentum investors? Let's find out.

Read source
gurufocus.com

Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health

Concentra (NYSE: CON), the nation's leader in occupational medicine, today announced that nationally recognized occupational medicine leader Jill Rosenthal, M

Read source
businesswire.com

Concentra Appoints Dr. Jill Rosenthal as Chief Medical Officer to Advance Clinical Innovation and Workforce Health

DALLAS--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational medicine, today announced that nationally recognized occupational medicine leader Jill Rosenthal, MD, MPH, will join the company Sept.…

Read source
gurufocus.com

Concentra Strengthens Workforce Health Access in Minnesota Through Acquisition

Concentra (NYSE: CON), the nation's leader in occupational and workforce health services, today announced completion of its acquisition of four Minnesota Occu

Read source
businesswire.com

Concentra Strengthens Workforce Health Access in Minnesota Through Acquisition

DALLAS & MINNEAPOLIS & ST. PAUL, Minn.--(BUSINESS WIRE)--Concentra® (NYSE: CON), the nation's leader in occupational and workforce health services, today announced completion of its acquisition of four Minnesota…

Read source
zacks.com

CON or MEDP: Which Is the Better Value Stock Right Now?

Investors interested in stocks from the Medical Services sector have probably already heard of Concentra Group (CON) and Medpace (MEDP). But which of these two stocks presents investors with the better value opportunity…

Read source

Corporate actions

Corporate action history

Dividend

Ex-dividend Aug 20, 2026

$0.0625

Quarterly

Record Aug 20, 2026 · Payment Aug 28, 2026

Dividend

Ex-dividend May 19, 2026

$0.0625

Quarterly

Record May 19, 2026 · Payment Jun 9, 2026

Dividend

Ex-dividend Mar 12, 2026

$0.0625

Quarterly

Record Mar 12, 2026 · Payment Mar 19, 2026

Dividend

Ex-dividend Dec 2, 2025

$0.0625

Quarterly

Record Dec 2, 2025 · Payment Dec 9, 2025

Dividend

Ex-dividend Aug 21, 2025

$0.0625

Quarterly

Record Aug 21, 2025 · Payment Aug 28, 2025

Dividend

Ex-dividend May 20, 2025

$0.0625

Quarterly

Record May 20, 2025 · Payment May 29, 2025

CON peers

Eli Lilly and Company logo

LLY

Eli Lilly and Company

$1,254.77

+0.83%

Johnson & Johnson logo

JNJ

Johnson & Johnson

$270.24

+1.07%

AbbVie Inc. logo

ABBV

AbbVie Inc.

$265.01

+1.21%

Merck & Co., Inc. logo

MRK

Merck & Co., Inc.

$152.55

+2.39%

UnitedHealth Group Incorporated logo

UNH

UnitedHealth Group Incorporated

$390.11

+1.37%

Novartis AG logo

NVS

Novartis AG

$158.86

+1.68%

ETFs holding CON

Funds reporting this stock among their holdings, ordered by reported position size.

iShares Core S&P Small-Cap ETF logoiShares Core S&P Small-Cap ETFIJR
Market value
257.38M
Weight
0.23%
AUM
111.19B USD
Expense ratio
0.06%
Price / 1D
$147.31+0.64%
Vanguard Morningstar Total Stock Market ETF logoVanguard Morningstar Total Stock Market ETFVTI
Market value
115.93M
Weight
0.01%
AUM
2.3T USD
Expense ratio
0.03%
Price / 1D
$378.24+0.44%
iShares Russell 2000 ETF logoiShares Russell 2000 ETFIWM
Market value
104.03M
Weight
0.13%
AUM
81.62B USD
Expense ratio
0.19%
Price / 1D
$299.96+0.77%
Schwab Fundamental International Large Company Index ETF logoSchwab Fundamental International Large Company Index ETFFNDF
Market value
92.1M
Weight
0.35%
AUM
26.15B USD
Expense ratio
0.25%
Price / 1D
$55.84+0.83%
Vanguard Morningstar Small-Cap ETF logoVanguard Morningstar Small-Cap ETFVB
Market value
83.81M
Weight
0.05%
AUM
183.4B USD
Expense ratio
0.03%
Price / 1D
$304.76+0.64%
Vanguard Morningstar Small-Cap Value ETF logoVanguard Morningstar Small-Cap Value ETFVBR
Market value
53.22M
Weight
0.08%
AUM
68.3B USD
Expense ratio
0.05%
Price / 1D
$249.18+0.68%
Vanguard Extended Market ETF logoVanguard Extended Market ETFVXF
Market value
43.36M
Weight
0.05%
AUM
93.7B USD
Expense ratio
0.05%
Price / 1D
$245.53+0.82%
State Street SPDR Portfolio S&P 600 Small Cap ETF logoState Street SPDR Portfolio S&P 600 Small Cap ETFSPSM
Market value
38.89M
Weight
0.23%
AUM
17.03B USD
Expense ratio
0.03%
Price / 1D
$57.28+0.61%

Continue in GoAI

Research CON

research.disclaimer